Jacek Capala
National Institutes of Health · 238 works · 5,873 citations · h-index 45
Top works
- Boron Neutron Capture Therapy for Glioblastoma Multiforme: Interim Results from the Phase I/II Dose-Escalation Studies
- Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results
- The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals
- Boron Neutron-Capture Therapy (BNCT) for Glioblastoma Multiforme (GBM) Using the Epithermal Neutron Beam at the Brookhaven National Laboratory
- Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden
- Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors
- Computational dosimetry and treatment planning for Boron Neutron Capture Therapy
- An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy
- Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden
- Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging
- Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)
- [18F]FBEM-ZHER2:342-Affibody molecule—a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography
- Fluorescence Lifetime Imaging System for in Vivo Studies
- Normal tissue protection for improving radiotherapy: Where are the Gaps?
- Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.
- Boron neutron capture therapy (BNCT): Implications of neutron beam and boron compound characteristics
- Performance of Silicon Microdosimetry Detectors in Boron Neutron Capture Therapy
- Accumulation of Boron in Malignant and Normal Cells Incubated In Vitro with Boronophenylalanine, Mercaptoborane or Boric Acid
- Changes inHER2Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and18F-Labeled Affibody Molecules
- PET/CT Imaging and Radioimmunotherapy of Prostate Cancer